Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
7512 | 1360 | 51.7 | 81% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
10 | 3 | IMMUNOLOGY//JOURNAL OF IMMUNOLOGY//IMMUNOL | 134299 |
140 | 2 | IMMUNOTHERAPY//DENDRITIC CELLS//CANCER IMMUNOLOGY IMMUNOTHERAPY | 23462 |
7512 | 1 | GLIOMA//GL261//BRAIN TUMOR PROGRAM | 1360 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | GLIOMA | authKW | 242616 | 24% | 3% | 322 |
2 | GL261 | authKW | 199686 | 1% | 68% | 13 |
3 | BRAIN TUMOR PROGRAM | address | 166740 | 2% | 29% | 26 |
4 | IMMUNOTHERAPY | authKW | 131916 | 20% | 2% | 273 |
5 | GLIOMA IMMUNOTHER Y GRP | address | 102038 | 1% | 45% | 10 |
6 | GLIOBLASTOMA | authKW | 98267 | 12% | 3% | 164 |
7 | RINDOPEPIMUT | authKW | 89799 | 0% | 67% | 6 |
8 | MOL MED HLTH CARE GRP | address | 67352 | 0% | 100% | 3 |
9 | MAXINE DUNITZ NEUROSURG | address | 63660 | 2% | 12% | 24 |
10 | UNIT MOL NEUROONCOL | address | 51305 | 1% | 29% | 8 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 9752 | 44% | 0% | 599 |
2 | Clinical Neurology | 9093 | 36% | 0% | 489 |
3 | Immunology | 2704 | 23% | 0% | 306 |
4 | Surgery | 1221 | 18% | 0% | 241 |
5 | Medicine, Research & Experimental | 736 | 10% | 0% | 132 |
6 | Neurosciences | 691 | 15% | 0% | 208 |
7 | Pathology | 402 | 6% | 0% | 75 |
8 | Biotechnology & Applied Microbiology | 47 | 4% | 0% | 55 |
9 | Cell Biology | 39 | 5% | 0% | 67 |
10 | Cell & Tissue Engineering | 29 | 1% | 0% | 7 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BRAIN TUMOR PROGRAM | 166740 | 2% | 29% | 26 |
2 | GLIOMA IMMUNOTHER Y GRP | 102038 | 1% | 45% | 10 |
3 | MOL MED HLTH CARE GRP | 67352 | 0% | 100% | 3 |
4 | MAXINE DUNITZ NEUROSURG | 63660 | 2% | 12% | 24 |
5 | UNIT MOL NEUROONCOL | 51305 | 1% | 29% | 8 |
6 | CLIN SCI H4 330 | 44902 | 0% | 100% | 2 |
7 | DIAGNOST MOL MED SERV | 44902 | 0% | 100% | 2 |
8 | MED VIRGINIA SURG NEUROSURG | 44902 | 0% | 100% | 2 |
9 | CHILD WOMAN | 40409 | 0% | 60% | 3 |
10 | MED ONCOL IMMUNOTHER Y PROGRAM | 40409 | 0% | 60% | 3 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF NEURO-ONCOLOGY | 50344 | 8% | 2% | 110 |
2 | DEVELOPMENTS IN ONCOLOGY | 19479 | 2% | 3% | 33 |
3 | JOURNAL OF NEUROSURGERY | 13781 | 7% | 1% | 91 |
4 | CANCER IMMUNOLOGY IMMUNOTHERAPY | 11363 | 3% | 1% | 47 |
5 | JOURNAL OF NEUROIMMUNOLOGY | 8281 | 4% | 1% | 50 |
6 | JOURNAL OF IMMUNOTHERAPY | 6425 | 2% | 1% | 22 |
7 | NEUROSURGERY | 5540 | 4% | 0% | 57 |
8 | ONCOIMMUNOLOGY | 3362 | 1% | 1% | 12 |
9 | CLINICAL CANCER RESEARCH | 3138 | 3% | 0% | 46 |
10 | NEUROSURGERY CLINICS OF NORTH AMERICA | 2795 | 1% | 1% | 12 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | GLIOMA | 242616 | 24% | 3% | 322 | Search GLIOMA | Search GLIOMA |
2 | GL261 | 199686 | 1% | 68% | 13 | Search GL261 | Search GL261 |
3 | IMMUNOTHERAPY | 131916 | 20% | 2% | 273 | Search IMMUNOTHERAPY | Search IMMUNOTHERAPY |
4 | GLIOBLASTOMA | 98267 | 12% | 3% | 164 | Search GLIOBLASTOMA | Search GLIOBLASTOMA |
5 | RINDOPEPIMUT | 89799 | 0% | 67% | 6 | Search RINDOPEPIMUT | Search RINDOPEPIMUT |
6 | CNS 1 | 50513 | 0% | 75% | 3 | Search CNS+1 | Search CNS+1 |
7 | GLIOMA VACCINE | 50513 | 0% | 75% | 3 | Search GLIOMA+VACCINE | Search GLIOMA+VACCINE |
8 | GLIOMA ASSOCIATED MICROGLIA MACROPHAGES | 44902 | 0% | 100% | 2 | Search GLIOMA+ASSOCIATED+MICROGLIA+MACROPHAGES | Search GLIOMA+ASSOCIATED+MICROGLIA+MACROPHAGES |
9 | GLIOBLASTOMA MULTIFORME | 42657 | 4% | 3% | 61 | Search GLIOBLASTOMA+MULTIFORME | Search GLIOBLASTOMA+MULTIFORME |
10 | MALIGNANT GLIOMA | 41976 | 3% | 4% | 43 | Search MALIGNANT+GLIOMA | Search MALIGNANT+GLIOMA |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | VAULEON, E , AVRIL, T , COLLET, B , MOSSER, J , QUILLIEN, V , (2010) OVERVIEW OF CELLULAR IMMUNOTHERAPY FOR PATIENTS WITH GLIOBLASTOMA.CLINICAL & DEVELOPMENTAL IMMUNOLOGY. VOL. . ISSUE . P. - | 84 | 61% | 24 |
2 | RUZEVICK, J , JACKSON, C , PHALLEN, J , LIM, M , (2012) CLINICAL TRIALS WITH IMMUNOTHERAPY FOR HIGH-GRADE GLIOMA.NEUROSURGERY CLINICS OF NORTH AMERICA. VOL. 23. ISSUE 3. P. 459 -+ | 70 | 58% | 8 |
3 | THOMAS, AA , ERNSTOFF, MS , FADUL, CE , (2012) IMMUNOTHERAPY FOR THE TREATMENT OF GLIOBLASTOMA.CANCER JOURNAL. VOL. 18. ISSUE 1. P. 59-68 | 55 | 65% | 16 |
4 | REARDON, DA , WUCHERPFENNIG, KW , FREEMAN, G , WU, CJ , CHIOCCA, EA , WEN, PY , CURRY, WT , MITCHELL, DA , FECCI, PE , SAMPSON, JH , ET AL (2013) AN UPDATE ON VACCINE THERAPY AND OTHER IMMUNOTHERAPEUTIC APPROACHES FOR GLIOBLASTOMA.EXPERT REVIEW OF VACCINES. VOL. 12. ISSUE 6. P. 597-615 | 85 | 38% | 22 |
5 | BADHIWALA, J , DECKER, WK , BERENS, ME , BHARDWAJ, RD , (2013) CLINICAL TRIALS IN CELLULAR IMMUNOTHERAPY FOR BRAIN/CNS TUMORS.EXPERT REVIEW OF NEUROTHERAPEUTICS. VOL. 13. ISSUE 4. P. 405 -424 | 64 | 55% | 4 |
6 | HAN, SJ , KAUR, G , YANG, I , LIM, M , (2010) BIOLOGIC PRINCIPLES OF IMMUNOTHERAPY FOR MALIGNANT GLIOMAS.NEUROSURGERY CLINICS OF NORTH AMERICA. VOL. 21. ISSUE 1. P. 1 -+ | 80 | 44% | 5 |
7 | HAN, SJ , ZYGOURAKIS, C , LIM, M , PARSA, AT , (2012) IMMUNOTHERAPY FOR GLIOMA PROMISES AND CHALLENGES.NEUROSURGERY CLINICS OF NORTH AMERICA. VOL. 23. ISSUE 3. P. 357 -+ | 74 | 44% | 8 |
8 | VAN GOOL, S , MAES, W , ARDON, H , VERSCHUERE, T , VAN CAUTER, S , DE VLEESCHOUWER, S , (2009) DENDRITIC CELL THERAPY OF HIGH-GRADE GLIOMAS.BRAIN PATHOLOGY. VOL. 19. ISSUE 4. P. 694 -712 | 66 | 49% | 43 |
9 | JACKSON, C , RUZEVICK, J , PHALLEN, J , BELCAID, Z , LIM, M , (2011) CHALLENGES IN IMMUNOTHERAPY PRESENTED BY THE GLIOBLASTOMA MULTIFORME MICROENVIRONMENT.CLINICAL & DEVELOPMENTAL IMMUNOLOGY. VOL. . ISSUE . P. - | 85 | 35% | 33 |
10 | HAMBARDZUMYAN, D , GUTMANN, DH , KETTENMANN, H , (2016) THE ROLE OF MICROGLIA AND MACROPHAGES IN GLIOMA MAINTENANCE AND PROGRESSION.NATURE NEUROSCIENCE. VOL. 19. ISSUE 1. P. 20 -27 | 35 | 41% | 16 |
Classes with closest relation at Level 1 |